Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 5, 2026

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

Postchemotherapy retroperitoneal lymph node dissection for testis cancer.

Michael C Risk1, Richard S Foster

  • 1Department of Urology, Indiana University School of Medicine, Indianapolis, IN, USA. mcrisk@iupui.edu

Expert Review of Anticancer Therapy
|December 21, 2010
PubMed
Summary

Postchemotherapy retroperitoneal lymph node dissection is a complex surgery for metastatic testicular cancer. This review covers its indications, techniques, and outcomes for selected patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prostate Cancer Treatment: Cryoablation in Context.

Cancers·2026
Same author

The Staging of High-risk and Non-metastatic Renal Cell Carcinoma Preoperatively Model Predicts Pathologic T3 Stage for Neoadjuvant Clinical Trial Enrollment.

Urology·2026
Same author

Percutaneous Microwave Ablation Preserves Renal Function with Similar Long Term Oncologic Outcomes Compared to Surgery for Clinical T1 Renal Cell Carcinoma.

Cancers·2026
Same author

Outcomes of Patients With Localized Renal Cell Carcinoma on Immunosuppression Following Solid Organ Transplantation.

Urology·2025
Same author

Short and long-term outcomes of arterial and caval replacement during postchemotherapy retroperitoneal lymph node dissection in metastatic testicular cancer.

Urologic oncology·2024
Same author

Cytoreductive nephrectomy in metastatic renal cell carcinoma.

The Cochrane database of systematic reviews·2024

Area of Science:

  • Oncology
  • Surgical Oncology
  • Urology

Background:

  • Metastatic testicular cancer requires multimodal treatment.
  • Postchemotherapy retroperitoneal lymph node dissection (RPLND) is a key component for select patients.
  • RPLND is technically challenging but offers significant benefits.

Purpose of the Study:

  • To review the current evidence and practices for postchemotherapy RPLND.
  • To discuss indications, technical advancements, and patient management.
  • To explore ongoing controversies and evolving aspects of the procedure.

Main Methods:

  • Literature review of studies on postchemotherapy RPLND.
  • Analysis of surgical techniques and outcomes.
  • Examination of patient selection criteria.

Related Experiment Videos

Last Updated: Jun 5, 2026

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

Main Results:

  • Postchemotherapy RPLND is beneficial for specific patient groups.
  • Technical refinements have improved outcomes.
  • Management strategies continue to evolve.

Conclusions:

  • Postchemotherapy RPLND remains a vital surgical option for metastatic testicular cancer.
  • Careful patient selection and surgical expertise are crucial.
  • Further research is needed to address current controversies.